Alison M. Shippy
About
In The Last Decade
Alison M. Shippy
17 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Pulmonary and Respiratory Medicine 1.6k
- Radiation 1.1k
- Radiology, Nuclear Medicine and Imaging 324
- Surgery 237
- Oncology 183
Countries citing papers authored by Alison M. Shippy
This map shows the geographic impact of Alison M. Shippy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison M. Shippy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison M. Shippy more than expected).
Fields of papers citing papers by Alison M. Shippy
This network shows the impact of papers produced by Alison M. Shippy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison M. Shippy. The network helps show where Alison M. Shippy may publish in the future.
Co-authorship network of co-authors of Alison M. Shippy
This figure shows the co-authorship network connecting the top 25 collaborators of Alison M. Shippy. A scholar is included among the top collaborators of Alison M. Shippy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison M. Shippy. Alison M. Shippy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Medical error in dermatology practice: Development of a classification system to drive priority setting in patient safety efforts | Journal of the American Academy of Dermatology | Alice J. Watson, James S. Taylor et al. | 23 |
| 2 | State of teledermatology programs in the United States | Journal of the American Academy of Dermatology | April W. Armstrong, Julie Wu et al. | 66 |
| 3 | Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer breakdown → | International Journal of Radiation Oncology*Biology*Physics | Michael J. Zeléfsky, Emily J. Levin et al. | 552 |
| 4 | Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate Cancer | European Urology | Michael J. Zeléfsky, Yoshiya Yamada et al. | 46 |
| 5 | Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes | International Journal of Radiation Oncology*Biology*Physics | Oren Cahlon, Michael J. Zeléfsky et al. | 199 |
| 6 | Long-Term Results of Conformal Radiotherapy for Prostate Cancer: Impact of Dose Escalation on Biochemical Tumor Control and Distant Metastases-Free Survival Outcomes | International Journal of Radiation Oncology*Biology*Physics | Michael J. Zeléfsky, Yoshiya Yamada et al. | 238 |
| 7 | Combined brachytherapy with external beam radiotherapy for localized prostate cancer: Reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy | Brachytherapy | Michael J. Zeléfsky, Zümre Arıcan Alıcıkuş et al. | 45 |
| 8 | Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate Cancer | The Journal of Urology | Michael J. Zeléfsky, Victor E. Reuter et al. | 132 |
| 9 | Pretreatment Nomogram Predicting Ten-Year Biochemical Outcome of Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Prostate Cancer | Urology | Michael J. Zeléfsky, Michael W. Kattan et al. | 48 |
| 10 | Intraoperative real-time planned conformal prostate brachytherapy: Post-implantation dosimetric outcome and clinical implications | Radiotherapy and Oncology | Michael J. Zeléfsky, Yoshiya Yamada et al. | 47 |
| 11 | Statin use and Clinical Outcomes After High Dose Radiotherapy for Prostate Cancer | International Journal of Radiation Oncology*Biology*Physics | Alison M. Shippy, Matthew S. Katz et al. | 10 |
| 12 | Comparison of 7-Year Outcomes Between LDR Brachytherapy and High Dose IMRT for Patients With Clinically Localized Prostate Cancer | International Journal of Radiation Oncology*Biology*Physics | Michael J. Zeléfsky, Yoshiya Yamada et al. | 5 |
| 13 | Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer | International Journal of Radiation Oncology*Biology*Physics | Michael J. Zeléfsky, Yoshiya Yamada et al. | 109 |
| 14 | 59 | International Journal of Radiation Oncology*Biology*Physics | Oren Cahlon, Michael J. Zeléfsky et al. | 5 |
| 15 | 58 | International Journal of Radiation Oncology*Biology*Physics | Alison M. Shippy, Margie Hunt et al. | 3 |
| 16 | Long-Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate Cancer | The Journal of Urology | Michael J. Zeléfsky, Heather Chan et al. | 354 |
| 17 | 16 | International Journal of Radiation Oncology*Biology*Physics | Michael J. Zeléfsky, Margie Hunt et al. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.